Forte Biosciences, Inc. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Forte Biosciences, Inc. (FBRX) is 1.53B

According to Forte Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.53B. This represents a change of 323.46% compared to the average of 360.81M of the last 4 quarters.

Forte Biosciences, Inc. (FBRX) Historical Enterprise Value (quarterly & annually)

How has FBRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Forte Biosciences, Inc. over the last ten years is 110.19M. The current 1.53B Enterprise Value has changed 138.56% with respect to the historical average. Over the past ten years (40 quarters), FBRX's Enterprise Value was at its highest in in the June 2026 quarter at 455.86M. The Enterprise Value was at its lowest in in the September 2022 quarter at -23795655.25.

Forte Biosciences, Inc. (FBRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Forte Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Forte Biosciences, Inc. (FBRX) Average Enterprise Value

How has FBRX Enterprise Value performed in the past?

The current Enterprise Value of Forte Biosciences, Inc. (FBRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Forte Biosciences, Inc. (FBRX) Enterprise Value vs. Peers

How is FBRX’s Enterprise Value compared to its peers?

Forte Biosciences, Inc.’s Enterprise Value is greater than Corbus Pharmaceuticals Holdings, Inc. (119.48M), greater than Applied Therapeutics, Inc. (5.42M), greater than Nkarta, Inc. (251.05M), greater than Alector, Inc. (184.90M), greater than Elicio Therapeutics, Inc. (26.70M), greater than PepGen Inc. (190.46M), greater than Cardiff Oncology, Inc. (96.85M), greater than Fate Therapeutics, Inc. (338.14M), greater than Actuate Therapeutics Inc (19.46M), greater than Molecular Partners AG (64.90M),

Build a custom stock screener for Forte Biosciences, Inc. (FBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Forte Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Forte Biosciences, Inc. (FBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Forte Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.